Zytoprotec
Phase 3Millions of patients worldwide are dependent on dialysis to survive. There are two types of dialysis (renal replacement therapy): Hemodialysis (mechanical blood purification) and peritoneal dialysis (PD), in which the blood is purified by a PD fluid in the abdomen. Our novel dialysate, PDprotec®, is designed to improve the outcomes of this treatment and reduce the burden of kidney failure for patients and healthcare providers. Zytoprotec expects the number of dialysis patients to increase sig...
About
Millions of patients worldwide are dependent on dialysis to survive. There are two types of dialysis (renal replacement therapy): Hemodialysis (mechanical blood purification) and peritoneal dialysis (PD), in which the blood is purified by a PD fluid in the abdomen. Our novel dialysate, PDprotec®, is designed to improve the outcomes of this treatment and reduce the burden of kidney failure for patients and healthcare providers. Zytoprotec expects the number of dialysis patients to increase sig...
Funding History
2Total raised: $17.5M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile